Piper Sandler maintains Solventum at Overweight, raises price target to $110 from $105
Piper Sandler kept Solventum's rating at Overweight and increased its price target to $110 from $105, suggesting a 26.2% upside from the Nov 5 close of $87.18.
How this was made

The 30-second read
Why it matters
The upgrade suggests a modest upside but limited market impact given the small size of the company.
Market read
A modest analyst upgrade with a small price target increase; limited immediate trading relevance.
What to watch
Potential hidden risk if the analyst's assumptions change.
Background
Piper Sandler upgraded Solventum to Overweight and lifted its price target from $105 to $110.
Market effects
none
none
none
Counterpoint
No strong contrarian case; price target raise is modest.
Key entities
- analystPiper Sandler
Equity research firm providing the rating and price target.


